News + Filings Transactions
|
Ahrens Brenton Karl
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 12/23/2022 | Iterum Therapeutics plc | ITRM | Grant | Stock Option (Right to Buy) | 29.1k | $0.81 | $23.6k | | 12/23/2022 |
| 09/25/2022 | Iterum Therapeutics plc | ITRM | Grant | Stock Option (Right to Buy) | 14.8k | $1.59 | $23.6k | | 09/25/2022 |
| 09/20/2022 | Iterum Therapeutics plc | ITRM | Sale | | 7.2k | $1.78 | $12.9k | See Footnote | 09/16/2022 |
| 09/19/2022 | Iterum Therapeutics plc | ITRM | Sale | | 15k | $1.77 | $26.5k | See Footnote | 09/16/2022 |
| 09/16/2022 | Iterum Therapeutics plc | ITRM | Sale | | 15k | $1.90 | $28.5k | See Footnote | 09/16/2022 |
| 09/15/2022 | Iterum Therapeutics plc | ITRM | Sale | | 15k | $2.02 | $30.3k | See Footnote | 09/13/2022 |
| 09/14/2022 | Iterum Therapeutics plc | ITRM | Sale | | 15k | $2.10 | $31.5k | See Footnote | 09/13/2022 |
| 09/13/2022 | Iterum Therapeutics plc | ITRM | Sale | | 15k | $2.14 | $32.1k | See Footnote | 09/13/2022 |
| 09/12/2022 | Iterum Therapeutics plc | ITRM | Sale | | 15k | $2.31 | $34.6k | See Footnote | 09/08/2022 |
| 09/09/2022 | Iterum Therapeutics plc | ITRM | Sale | | 15k | $2.32 | $34.7k | See Footnote | 09/08/2022 |
| 09/08/2022 | Iterum Therapeutics plc | ITRM | Sale | | 3.3k | $2.26 | $7.5k | See Footnote | 09/08/2022 |
| 06/25/2022 | Iterum Therapeutics plc | ITRM | Grant | Stock Option (Right to Buy) | 113.3k | $0.20 | $22.7k | | 06/25/2022 |
| 06/15/2022 | Iterum Therapeutics plc | ITRM | Grant | Share Option (Right to Buy) | 647.1k | $0.21 | $135.9k | | 06/15/2022 |
| 03/25/2022 | Iterum Therapeutics plc | ITRM | Grant | Stock Option (Right to Buy) | 47.4k | $0.45 | $21.3k | | 03/25/2022 |
| 06/23/2021 | Iterum Therapeutics plc | ITRM | Grant | Stock Option (Right to Buy) | 64.7k | $2.01 | $130.1k | | 06/23/2021 |
| 01/21/2020 | Iterum Therapeutics plc | ITRM | Grant | 6.500% Exchangeable Senior Subordinated Note due 2025 | 0 | $2,000,000.00 | $0 | By Canaan X L.P | 01/21/2020 |
| 06/13/2019 | Iterum Therapeutics plc | ITRM | Grant | Stock Option (Right to Buy) | 19.7k | $6.74 | $132.6k | | 06/13/2019 |
| 05/24/2019 | Iterum Therapeutics plc | ITRM | Exercise | Restricted Stock Units | 6.2k | $0.00 | $0 | | 05/24/2019 |
| 05/30/2018 | Iterum Therapeutics plc | ITRM | Conversion | Ordinary Shares | 721.4k | $0.00 | $0 | By Canaan X, L.P. | 05/30/2018 |
| 05/30/2018 | Iterum Therapeutics plc | ITRM | Conversion | Ordinary Shares | 275.4k | $0.00 | $0 | By Canaan X, L.P. | 05/30/2018 |
| 05/30/2018 | Iterum Therapeutics plc | ITRM | Conversion | Ordinary Shares | 229.7k | $0.00 | $0 | By Canaan X, L.P. | 05/30/2018 |
| 05/30/2018 | Iterum Therapeutics plc | ITRM | Purchase | Ordinary Shares | 506.7k | $13.00 | $6.6M | By Canaan X, L.P. | 05/30/2018 |
| 05/30/2018 | Iterum Therapeutics plc | ITRM | Conversion | Series A Preferred Shares | 721.4k | $0.00 | $0 | By Canaan X, L.P. | 05/30/2018 |
| 05/30/2018 | Iterum Therapeutics plc | ITRM | Conversion | Series B-1 Preferred Shares | 275.4k | $0.00 | $0 | By Canaan X, L.P. | 05/30/2018 |
| 05/30/2018 | Iterum Therapeutics plc | ITRM | Conversion | Series B-2 Preferred Shares | 229.7k | $0.00 | $0 | By Canaan X, L.P. | 05/30/2018 |
| 05/24/2018 | Iterum Therapeutics plc | ITRM | Grant | Restricted Stock Units | 6.2k | $0.00 | $0 | | 05/24/2018 |
| 07/24/2012 | Durata Therapeutics, Inc. | DRTX | Conversion | Common Stock | 1.3M | $0.00 | $0 | See footnote | 07/24/2012 |
| 07/24/2012 | Durata Therapeutics, Inc. | DRTX | Purchase | Common Stock | 555.6k | $9.00 | $5M | See footnote | 07/24/2012 |
| 07/24/2012 | Durata Therapeutics, Inc. | DRTX | Conversion | Series A Preferred Stock | 10.8M | $0.00 | $0 | See footnote | 07/24/2012 |
| 02/28/2012 | Durata Therapeutics, Inc. | DRTX | Grant | Stock Option (right to buy) | 6.2k | $2.08 | $13k | | 07/24/2012 |
|